Last reviewed · How we verify
Nexrutine
Nexrutine is a Small molecule drug developed by The University of Texas Health Science Center at San Antonio. It is currently in discontinued development. Also known as: bark extract of Phellodendron amurense.
At a glance
| Generic name | Nexrutine |
|---|---|
| Also known as | bark extract of Phellodendron amurense |
| Sponsor | The University of Texas Health Science Center at San Antonio |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nexrutine CI brief — competitive landscape report
- Nexrutine updates RSS · CI watch RSS
- The University of Texas Health Science Center at San Antonio portfolio CI
Frequently asked questions about Nexrutine
What is Nexrutine?
Nexrutine is a Small molecule drug developed by The University of Texas Health Science Center at San Antonio.
Who makes Nexrutine?
Nexrutine is developed by The University of Texas Health Science Center at San Antonio (see full The University of Texas Health Science Center at San Antonio pipeline at /company/the-university-of-texas-health-science-center-at-san-antonio).
Is Nexrutine also known as anything else?
Nexrutine is also known as bark extract of Phellodendron amurense.
What development phase is Nexrutine in?
Nexrutine is in discontinued.
Related
- Manufacturer: The University of Texas Health Science Center at San Antonio — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: bark extract of Phellodendron amurense
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing